Clomifene
- Generic Name
- Clomifene
- Brand Names
- Clomid
- Drug Type
- Small Molecule
- Chemical Formula
- C26H28ClNO
- CAS Number
- 911-45-5
- Unique Ingredient Identifier
- 1HRS458QU2
- Background
A triphenyl ethylene stilbene derivative which is an estrogen agonist or antagonist depending on the target tissue.
- Indication
Used mainly in female infertility due to anovulation (e.g. due to polycystic ovary syndrome) to induce ovulation.
- Associated Conditions
- Ovulatory Dysfunction
- Associated Therapies
- -
Efficacy Study of Raloxifene to Induce Ovulation in Polycystic Ovarian Syndrome
- Conditions
- Interventions
- First Posted Date
- 2012-05-30
- Last Posted Date
- 2018-09-20
- Lead Sponsor
- Bruce Lessey
- Target Recruit Count
- 3
- Registration Number
- NCT01607320
- Locations
- 🇺🇸
Greenville Hospital System, Greenville, South Carolina, United States
Clomifene Citrate as First Line Treatment in in Vitro Fertilization Cycles for Patients With Lower Ovarian Reserve
- Conditions
- Interventions
- First Posted Date
- 2011-07-08
- Last Posted Date
- 2011-07-12
- Target Recruit Count
- 289
- Registration Number
- NCT01389713
- Locations
- 🇮🇹
Fondazione Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) Response to Low Dose Clomiphene Citrate in Normally Menstruating Fertile Women
- Conditions
- First Posted Date
- 2011-04-22
- Last Posted Date
- 2012-12-20
- Lead Sponsor
- Milton S. Hershey Medical Center
- Target Recruit Count
- 25
- Registration Number
- NCT01340521
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Differential Effects of Clomiphene Citrate in Women Undergoing Superovulation
- First Posted Date
- 2011-02-07
- Last Posted Date
- 2016-06-28
- Lead Sponsor
- University of Utah
- Target Recruit Count
- 20
- Registration Number
- NCT01291056
- Locations
- 🇺🇸
University of Utah, Salt Lake City, Utah, United States
Influence of Pharmacogenetic Factors, Paroxetine and Clarithromycin on Pharmacokinetics of Clomiphene
- First Posted Date
- 2011-02-04
- Last Posted Date
- 2015-02-24
- Target Recruit Count
- 20
- Registration Number
- NCT01289756
- Locations
- 🇩🇪
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology and University of Tuebingen, Stuttgart, BW, Germany
Mild Stimulation Protocol Versus Microdose Gonadotropin-releasing Hormone Agonist Flare up Protocol in Poor Responders
- First Posted Date
- 2010-10-01
- Last Posted Date
- 2010-10-01
- Lead Sponsor
- Yazd Medical University
- Target Recruit Count
- 159
- Registration Number
- NCT01213147
- Locations
- 🇮🇷
Yazd Research and Clinical Center for Infertility, Yazd, Iran, Islamic Republic of
Minimal Stimulation or Clomiphene Citrate in Treatment of Polycystic Ovary Syndrome
- Conditions
- Interventions
- First Posted Date
- 2010-07-07
- Last Posted Date
- 2010-07-19
- Lead Sponsor
- Mansoura University
- Target Recruit Count
- 113
- Registration Number
- NCT01157312
- Locations
- 🇪🇬
Mansoura University Hospitals,OB/GYN department, Mansoura, Dakahlia Governorate, Egypt
Hypogonadism in Young Men With Type 2 Diabetes
- Conditions
- Interventions
- First Posted Date
- 2010-07-01
- Last Posted Date
- 2019-10-04
- Lead Sponsor
- State University of New York at Buffalo
- Target Recruit Count
- 5
- Registration Number
- NCT01155518
- Locations
- 🇺🇸
Millard Fillmore Gates Hospital, Buffalo, New York, United States
Assessment of Multiple Intrauterine Gestations From Ovarian Stimulation
- Conditions
- Interventions
- First Posted Date
- 2010-01-08
- Last Posted Date
- 2015-02-02
- Lead Sponsor
- Yale University
- Target Recruit Count
- 900
- Registration Number
- NCT01044862
- Locations
- 🇺🇸
University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
🇺🇸University of Colorado, Aurora, Colorado, United States
🇺🇸University of Alabama Birmingham, Birmingham, Alabama, United States
Traditional Clomiphene Citrate Administration vs. Stair-step Approach
- Conditions
- Interventions
- First Posted Date
- 2009-11-05
- Last Posted Date
- 2018-01-08
- Lead Sponsor
- University of Oklahoma
- Target Recruit Count
- 120
- Registration Number
- NCT01008319
- Locations
- 🇺🇸
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.